Literature DB >> 6354228

Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol.

E Rowland, P Razis, D Sugrue, D M Krikler.   

Abstract

The action of nifedipine given first intravenously and then orally was studied in nine patients undergoing investigation for angina pectoris who were already receiving atenolol (100-200 mg/daily) and who had been shown to be fully beta blocked (reduction in maximal heart rate by greater than 25%). Intravenous nifedipine 7.5 micrograms/kg reduced both systolic blood pressure and left ventricular pressure (dP/dt) transiently; both values were significantly lower five and 10 minutes after the infusion of nifedipine but were not significantly different from control values at 20 minutes. There was minimal but pronounced depression of atrioventricular nodal function after giving intravenous nifedipine, though this was detected only when sensitive tests of atrioventricular nodal function were used. These effects were also transient, showing no significant change from control values at 20 minutes. Atrioventricular nodal conduction time and sinus rate were unchanged. Radionuclide angiography of patients taking the oral combination of atenolol and nifedipine for chronic angina showed no change in ejection fraction compared with those taking atenolol alone, but there was a small increase in peak ejection rate. Resting blood pressure and heart rate were unchanged and the PR interval did not lengthen. Peak heart rate and systolic blood pressure showed no alteration on exercise testing when the drugs were combined compared with the response with atenolol alone. Despite the negative inotropic influence when nifedipine was given intravenously, the absence of haemodynamic deterioration when oral nifedipine is combined with atenolol has confirmed that this combination can be used safely in patients with normal left ventricular function. The minimal changes in atrioventricular nodal function cannot be detected on the surface electrocardiogram and are not of clinical importance in patients with normal conduction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6354228      PMCID: PMC481427          DOI: 10.1136/hrt.50.4.383

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  35 in total

1.  Calcium-channel blockers and beta blockers: advantages and disadvantages of combination therapy in chronic stable angina pectoris.

Authors:  D M Krikler; L Harris; E Rowland
Journal:  Am Heart J       Date:  1982-09       Impact factor: 4.749

Review 2.  Mechanism of action of calcium-channel-blocking agents.

Authors:  E Braunwald
Journal:  N Engl J Med       Date:  1982-12-23       Impact factor: 91.245

3.  Nifedipine and beta-blockade as a cause of cardiac failure.

Authors:  R H Robson; M C Vishwanath
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-09

4.  Combined therapy with verapamil and propranolol in chronic stable angina.

Authors:  B Subramanian; M J Bowles; A B Davies; E B Raftery
Journal:  Am J Cardiol       Date:  1982-01       Impact factor: 2.778

5.  Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris.

Authors:  M B Leon; D R Rosing; R O Bonow; L C Lipson; S E Epstein
Journal:  Am J Cardiol       Date:  1981-07       Impact factor: 2.778

6.  Influence of nifedipine left ventricular systolic and diastolic function. Relationships to manifestations of ischemia and congestive failure.

Authors:  P A Ludbrook; A J Tiefenbrunn; B E Sobel
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

7.  Hemodynamic and electrophysiologic effects of verapamil and nifedipine in patients on propranolol.

Authors:  M D Winniford; R V Markham; B G Firth; P Nicod; L D Hillis
Journal:  Am J Cardiol       Date:  1982-10       Impact factor: 2.778

8.  Combined acebutolol/nifedipine therapy in patients with chronic coronary artery disease: additional improvement of ischemia-induced left ventricular dysfunction.

Authors:  M Pfisterer; J Müller-Brand; F Burkart
Journal:  Am J Cardiol       Date:  1982-04-01       Impact factor: 2.778

9.  Effect of verapamil and nifedipine on left ventricular function at rest and during exercise in patients with Prinzmetal's variant angina pectoris.

Authors:  S M Johnson; D R Mauritson; J Corbett; G J Dehmer; S E Lewis; J T Willerson; L D Hillis
Journal:  Am J Cardiol       Date:  1981-06       Impact factor: 2.778

10.  [Hemodynamic effects of the association of nifedipine and acebutolol].

Authors:  J P Monassier; P M Coulbois; J W Doll; J B Weiss; B Basch; C Monassier
Journal:  Arch Mal Coeur Vaiss       Date:  1982-03
View more
  19 in total

1.  Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatment.

Authors:  P Rocha; M Guerret; D David; X Marchand; J C Kahn
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

Review 2.  beta-blockers. Drug interactions of clinical significance.

Authors:  I Blaufarb; T M Pfeifer; W H Frishman
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

Review 3.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

4.  The effects of intravenous nifedipine on cardiac hemodynamics and contractility in patients with coronary artery disease in the presence or absence of beta adrenergic blockade.

Authors:  O Visioli; R Bolognesi; F Cucchini; R Ferrari
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

Review 5.  Beta-adrenoceptor antagonists plus nifedipine in the treatment of chronic stable angina pectoris.

Authors:  V F Challenor; D G Waller; C F George
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

6.  Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function.

Authors:  I N Findlay; K MacLeod; M Ford; G Gillen; A T Elliott; H J Dargie
Journal:  Br Heart J       Date:  1986-03

Review 7.  Verapamil in arrhythmia.

Authors:  D M Krikler
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

8.  A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris.

Authors:  I N Findlay; K MacLeod; G Gillen; A T Elliott; T Aitchison; H J Dargie
Journal:  Br Heart J       Date:  1987-04

9.  Atenolol with and without nifedipine in the treatment of angina pectoris. Preliminary report.

Authors:  M Sandberg; R A Foale
Journal:  Drugs       Date:  1988       Impact factor: 9.546

10.  Intrinsic and reflex actions of verapamil and nifedipine: assessment in normal subjects by noninvasive techniques and autonomic blockade.

Authors:  H C Stern; J H Matthews; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.